References
1Zuccoli G, Siddiqui N, Cravo I, Bailey A, Gallucci M, Harper CG. Neuroimaging findings in alcohol-related encephalopathies. AJR Am J Roentgenol 2010; 195: 1378-84.
2Pfefferbaum A, Sullivan EV. Microstructural but not macrostructural disruption of white matter in women with chronic alcoholism. Neuroimage 2002; 15: 708-18.
3Bendszus M, Weijers HG, Wiesbeck G, Warmuth-Metz M, Bartsch AJ, Engels S, et al. Sequential MR imaging and proton MR spectroscopy in patients who underwent recent detoxification for chronic alcoholism: correlation with clinical and neuropsychological data. AJNR Am J Neuroradiol 2001; 22: 1926-32.
4Durazzo TC, Gazdzinski S, Banys P, Meyerhoff DJ. Cigarette smoking exacerbates chronic alcohol-induced brain damage: a preliminary metabolite imaging study. Alcohol Clin Exp Res 2004; 28: 1849-60.
5Schroth G, Naegele T, Klose U, Mann K, Petersen D. Reversible brain shrinkage in abstinent alcoholics, measured by MRI. Neuroradiology 1988; 30: 385-9.
6Zipursky RB, Lim KC, Pfefferbaum A. MRI study of brain changes with short-term abstinence from alcohol. Alcohol Clin Exp Res 1989; 13: 664-6.
7Nekoukar Z, Zakariaei Z, Taghizadeh F, Musavi F, Banimostafavi ES, Sharifpour A, et al. Methanol poisoning as a new world challenge: a review. Ann Med Surg (Lond) 2021; 66: 102445.
8Altintas F, Kaya A, Cesme DH, Alkan A. Importance of Susceptibility-weighted-imaging in methanol toxicity. J Coll Physicians Surg Pak 2022; 32: 1495-7.
9Patankar T, Bichile L, Karnad D, Prasad S, Rathod K. Methanol poisoning: brain computed tomography scan findings in four patients. Australas Radiol 1999; 43: 526-8.
10Aquilonius SM, Askmark H, Enoksson P, Lundberg PO, Moström U. Computerised tomography in severe methanol intoxication. Br Med J 1978; 2: 929-30.
11Deniz S, Oppenheim C, Lehéricy S, Sharshar T, Lalam TF, Dormont D, et al. Diffusion-weighted magnetic resonance imaging in a case of methanol intoxication. Neurotoxicology 2000; 21: 405-8.
12Server A, Hovda KE, Nakstad PH, Jacobsen D, Dullerud R, Haakonsen M. Conventional and diffusion-weighted MRI in the evaluation of methanol poisoning. Acta Radiol 2003; 44: 691-5.
13Anderson TJ, Shuaib A, Becker WJ. Neurologic sequelae of methanol poisoning. CMAJ 1987; 136: 1177-9.
14Zuccoli G, Siddiqui N, Cravo I, Bailey A, Gallucci M, Harper CG. Neuroimaging findings in alcohol-related encephalopathies. AJR Am J Roentgenol 2010; 195: 1378-84.
15Ihn YK, Hwang SS, Park YH. Acute Marchiafava-Bignami disease: diffusion-weighted MRI in cortical and callosal involvement. Yonsei Med J 2007; 48: 321-4.
16Arbelaez A, Pajon A, Castillo M. Acute Marchiafava-Bignami disease: MR findings in two patients. AJNR Am J Neuroradiol 2003; 24: 1955-7.
17Ménégon P, Sibon I, Pachai C, Orgogozo JM, Dousset V. Marchiafava-Bignami disease: diffusion-weighted MRI in corpus callosum and cortical lesions. Neurology 2005; 65: 475-7.
18Sair HI, Mohamed FB, Patel S, Kanamalla US, Hershey B, Hakma Z, et al. Diffusion tensor imaging and fiber-tracking in Marchiafava-Bignami disease. J Neuroimaging 2006; 16: 281-5.
19Bano S, Mehra S, Yadav SN, Chaudhary V. Marchiafava-Bignami disease: role of neuroimaging in the diagnosis and management of acute disease. Neurol India 2009; 57: 649-52.
